Analysts

Paradigm Capital says Firan Technology has 48 per cent upside

Firan Technology Group’s (TSX:FTG) quarterly results came in better than expected, says Gabriel Leung, analyst with Beacon Securities, whose client update on Thursday reiterated his “Buy” recommendation with a raised target price of $4.00.

Aerospace and defence electronics supplier Firan Technology reported its Q2 financials on Wednesday, with record sales of $28.9 million, a 13 per cent increase over Q2/17, and featuring a 42 per cent boost in its aerospace segment compared to Q2/17 at $12.7 million.

“The second quarter of 2018 began to demonstrate the earnings benefits from our acquisitions in 2016,” says Brad Bourne, President and CEO, in a statement. “While we continued to experience some increased costs in the quarter related to the transition, we also achieved a dramatic improvement in our net earnings and cash flow.”

The $28.9 million in revenues beat Leung’s estimate of $26.0 million, while FTG’s Q2 EBITDA of $3.5 was better than Leung’s $2.3 million. The analyst noted the company’s free cash flow for the quarter was $3.6 million, with an operating cash flow of $4 million against capital expenditures of $414,000 and deferred development costs of $67,000.

Leung said that he anticipates FTG will get modest cost savings as the transition costs associated with its Chatsworth Aerospace facility are eliminated.

“Bottom-line, we believe fiscal Q2 was an outstanding quarter both in terms of sales, bookings and cost improvements,” says Leung. “With a strong demand backdrop (despite lingering uncertainties from potential trade wars), along with improving operations, we believe FTG’s near-term growth prospects look promising.”

Leung sees FTG generating EBITDA of $10.4 million on revenue of $108.3 million in fiscal 2018. The analyst’s $4.00 target (was $3.00) is based on his 10x FY18e EV/EBITDA valuation and represents a projected return of 48 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: ftg
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago